{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dalcetrapib", "query": { "intervention": "Dalcetrapib" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T07:14:43.339Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00353522", "title": "A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Coronary Heart Disease" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "dalcetrapib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 135, "start_date": "2006-07", "completion_date": "2008-10", "has_results": true, "last_update_posted_date": "2020-01-27", "last_synced_at": "2026-09-03T07:14:43.339Z", "location_count": 10, "location_summary": "Chicago, Illinois • Indianapolis, Indiana • Iowa City, Iowa + 6 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00353522" }, { "nct_id": "NCT00697203", "title": "A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dyslipidemia" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Pravastatin", "type": "DRUG" }, { "name": "Dalcetrapib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 292, "start_date": "2005-07", "completion_date": "2006-05", "has_results": true, "last_update_posted_date": "2020-01-02", "last_synced_at": "2026-09-03T07:14:43.339Z", "location_count": 33, "location_summary": "Mobile, Alabama • Scottsdale, Arizona • Newark, Delaware + 30 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Newark", "state": "Delaware" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00697203" }, { "nct_id": "NCT00400439", "title": "A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Coronary Heart Disease" ], "interventions": [ { "name": "dalcetrapib (RO4607381)", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 77, "start_date": "2007-01", "completion_date": "2008-01", "has_results": true, "last_update_posted_date": "2020-01-03", "last_synced_at": "2026-09-03T07:14:43.339Z", "location_count": 9, "location_summary": "Indianapolis, Indiana • Iowa City, Iowa • Louisville, Kentucky + 5 more", "locations": [ { "city": "Indianapolis", "state": "Indiana" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00400439" }, { "nct_id": "NCT00658515", "title": "A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Coronary Heart Disease" ], "interventions": [ { "name": "Dalcetrapib (RO4607381)", "type": "DRUG" }, { "name": "Evidence-based medical care for Acute Coronary Syndrome", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 15871, "start_date": "2008-04", "completion_date": "2012-09", "has_results": true, "last_update_posted_date": "2020-01-03", "last_synced_at": "2026-09-03T07:14:43.339Z", "location_count": 513, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Tuscaloosa, Alabama + 400 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00658515" }, { "nct_id": "NCT05918861", "title": "Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Coronary Syndrome" ], "interventions": [ { "name": "Dalcetrapib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "DalCor Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 2000, "start_date": "2023-10-03", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2026-06-22", "last_synced_at": "2026-09-03T07:14:43.339Z", "location_count": 186, "location_summary": "Alexander City, Alabama • Birmingham, Alabama • Fairhope, Alabama + 163 more", "locations": [ { "city": "Alexander City", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Fairhope", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT05918861" }, { "nct_id": "NCT02525939", "title": "Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Coronary Syndrome" ], "interventions": [ { "name": "dalcetrapib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "DalCor Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 6147, "start_date": "2016-04", "completion_date": "2021-10", "has_results": true, "last_update_posted_date": "2022-10-12", "last_synced_at": "2026-09-03T07:14:43.339Z", "location_count": 122, "location_summary": "Alexander City, Alabama • Huntsville, Alabama • Mobile, Alabama + 119 more", "locations": [ { "city": "Alexander City", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Cottonwood", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02525939" }, { "nct_id": "NCT01323153", "title": "A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Coronary Heart Disease" ], "interventions": [ { "name": "dalcetrapib", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 300, "start_date": "2011-03", "completion_date": "2012-03", "has_results": true, "last_update_posted_date": "2019-07-30", "last_synced_at": "2026-09-03T07:14:43.339Z", "location_count": 6, "location_summary": "Pensacola, Florida • Saginaw, Michigan • Saint Cloud, Minnesota + 2 more", "locations": [ { "city": "Pensacola", "state": "Florida" }, { "city": "Pensacola", "state": "Florida" }, { "city": "Saginaw", "state": "Michigan" }, { "city": "Saint Cloud", "state": "Minnesota" }, { "city": "Syracuse", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01323153" }, { "nct_id": "NCT01516541", "title": "A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)" ], "interventions": [ { "name": "Background care", "type": "OTHER" }, { "name": "Placebo", "type": "DRUG" }, { "name": "dalcetrapib", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 2220, "start_date": "2012-01", "completion_date": "2012-07", "has_results": false, "last_update_posted_date": "2016-11-02", "last_synced_at": "2026-09-03T07:14:43.339Z", "location_count": 121, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Anaheim, California + 112 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01516541" }, { "nct_id": "NCT01059682", "title": "A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cardiovascular Disease" ], "interventions": [ { "name": "Dalcetrapib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 936, "start_date": "2010-01", "completion_date": "2011-09", "has_results": true, "last_update_posted_date": "2020-03-24", "last_synced_at": "2026-09-03T07:14:43.339Z", "location_count": 41, "location_summary": "Los Angeles, California • Torrance, California • Boulder, Colorado + 36 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Greeley", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01059682" }, { "nct_id": "NCT00655473", "title": "A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Coronary Heart Disease" ], "interventions": [ { "name": "Dalcetrapib (RO4607381)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 130, "start_date": "2008-03", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2020-01-03", "last_synced_at": "2026-09-03T07:14:43.339Z", "location_count": 11, "location_summary": "Jacksonville, Florida • Royal Oak, Michigan • Minneapolis, Minnesota + 7 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Royal Oak", "state": "Michigan" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00655473" } ] }